NWRN fundamentals
An in-depth look to NEWRON PHARMA N operating, investing, and financing activities
NWRN free cash flow for H2 24 is -8.14 M CHF. For 2024, NWRN free cash flow was -16.79 M CHF and operating cash flow was -16.78 M CHF.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CHF
TTM